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Abstract
Background: Psychosocial problems in cancer patients are often unrecognized and untreated due to the low
awareness of the existence of these problems or pressures of time. The awareness of the need to identify
psychosocial problems in cancer patients is growing and has affected the development of screening instruments.
This study explored the usefulness and feasibility of using a screening instrument (SIPP: Screening Inventory of
Psychosocial Problems) to identify psychosocial problems in cancer patients receiving curative radiotherapy
treatment (RT).
Methods: The study was conducted in a radiation oncology department in the Netherlands. Several methods were
used to document the usefulness and feasibility of the SIPP. Data were collected using self-report questionnaires
completed by seven radiotherapists and 268 cancer patients.
Results: Regarding the screening procedure 33 patients were offered to consult a psychosocial care provider (e.g.
social worker, psychologist) during the first consultation with their radiotherapist. Of these patients, 31 patients
suffered from at least sub-clinical symptoms and two patients hardly suffered from any symptoms. Patients’
acceptance rate 63.6% (21/33) was high. Patients were positive about the content of the SIPP (mean scores vary
from 8.00 to 8.88, out of a range between 0 and 10) and about the importance of discussing items of the SIPP
with their radiotherapist (mean score = 7.42). Radiotherapists’ perspectives about the contribution of the SIPP to
discuss the different psychosocial problems were mixed (mean scores varied from 3.17 to 4.67). Patients were more
positive about discussing items of the SIPP if the radiotherapists had positive attitudes towards screening and
discussing psychosocial problems.
Conclusions: The screening procedure appeared to be feasible in a radiotherapy department. In general, patients’
perspectives were at least moderate. Radiotherapists considered the usefulness and feasibility of the SIPP generally
to be lower, but their evaluations were mixed. A positive attitude to using screening instruments like the SIPP
needs to be encouraged among radiotherapists, as this may not only improve the usefulness of a screening
instrument, but also patients’ satisfaction with care.
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Cancer, as well as its sometimes invasive and aggressive
treatment, has a great impact on a patient’s life. Pre-
vious studies have highlighted that cancer patients
undergoing radiotherapy treatment (RT) may experience
psychosocial problems such as symptoms of depression
and anxiety [1,2], which may negatively affect health and
treatment-related outcomes [3]. It is important to detect
psychosocial problems at an early stage because treat-
ment of sub-clinical symptoms of psychosocial problems
may prevent further deterioration in the patient and the
development of psychiatric co-morbidity [4]. Yet, psy-
chosocial problems are often unrecognized and
untreated due to the low awareness of the existence of
psychosocial problems or pressures of time [5,6].
Furthermore, physicians are more focused on physical
symptoms [7-9], and may feel more able to help with
physical problems than with emotional ones [10].
Another aspect is that cancer patients do not tend to
report psychological problems to their physician; some
patients may regard psychosocial care as stigmatizing
and on this basis be reluctant to seek help [6,11].
Awareness of the need for identifying psychosocial
problems is growing, resulting in the development of
screening instruments [12]. Several studies examined the
use of screening instruments [12-16]. Most studies
reported that using these instruments gave better insight
into patients’ psychosocial problems and facilitated
patient-physician communication on the topics of the
instrument [7,12,17]. Our study, a randomized con-
trolled trial recently showed that using a simple screen-
ing instrument in a radiation oncology department can
be valuable in timely treatment of these problems but,
however, no significant effects were observed for the
number of referred patients, nor for improvement of the
patients-radiotherapist communication (paper sub-
mitted, article available on request).
In parallel to this trial, a process evaluation was car-
ried out. The purpose of this process evaluation was to
evaluate the feasibility and usefulness of this screening
instrument (SIPP: Screening Inventory of Psychosocial
Problems) and to identify factors that may explain the
lack of effectiveness on referral patterns and patients-
radiotherapist communication in patients receiving cura-
tive RT. The specific aims were:
1. To gain insight into the procedure of using the
SIPP in a radiation oncology department.
2. To investigate the degree to which the SIPP was
considered useful and feasible by both radiotherapists
and cancer patients. Feasibility, including acceptability,
of screening instruments is an important aspect that
determines successful implementation of such tools in
radiation oncology departments [18,19].
To investigate whether perspectives of patients and
radiotherapists on the usefulness and feasibility of the
SIPP are associated. We hypothesized that more positive
attitudes of radiotherapists towards discussing psychoso-
cial problems in daily practice will result in more posi-
tive perspectives on the usefulness of the SIPP among
patients. Previous studies have reported that the way
physicians address psychosocial problems affects how
patients perceive the interactions with their physician
[20,21].
Methods
Study design and participants
This process evaluation study, part of a larger clustered
randomized controlled trial [22], used several methods
to document the usefulness and feasibility of the SIPP, a
screening instrument to identify different psychosocial
problems in cancer patients (see Appendix A). The
study was conducted between April 2008 and October
2009 at Institute Verbeeten (BVI), a radiation oncology
department in the city of Tilburg in the south of the
Netherlands. Patients with the following characteristics
were included: cancer diagnosis of lung, prostate, blad-
der, rectum, breast, cervix, skin, endometrial or non-
Hodgkin lymphoma; age over 18 years; patients without
metastases; and able to provide written informed con-
sent. Exclusion criteria were: receiving palliative treat-
ment; receiving ≤ 10 fractions of radiotherapy treatment;
unable to read and speak Dutch and unable to complete
questionnaires (e.g., too sick). Seven radiotherapists
working at BVI were randomly included in this study.
Patients were linked to their radiotherapist. This study
was approved by the Medical Ethics Committee of the
Twee Steden Hospital in Tilburg, the Netherlands.
Intervention
The SIPP was chosen as the intervention screening
instrument because it is a Dutch, simple screening
instrument designed to identify multiple aspects of psy-
chosocial problems in cancer patients [23]. Furthermore,
it is used in several hospitals and studies [14,24-26]. Psy-
chometric properties of the SIPP were studied recently
and found acceptable [23]. The SIPP comprises 24 items
and assesses physical complaints (seven items, Cron-
bach’s alpha = 0.76), psychological complaints (10 items,
Cronbach’s alpha = 0.89), social problems (four items,
Cronbach’s alpha = 0.56), and sexual problems (three
items, Cronbach’s alpha = 0.51). Items are rated on a
three-point scale of “0” (No), “1” (Sometimes) and “2”
(Yes) with an additional option of “Not Applicable”
(score 0) for the sexual problems subscale (for items see
Appendix A). Higher scores indicate higher levels of
psychosocial problems. Prevalence rates of patients with
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cial problems were assessed with the SIPP by using sui-
table cut-off scores (see footnote Table 1) [23].
Patients received the SIPP before the first consultation
with their radiotherapist and before the consultation at
the end of their RT period since these time points were
considered relevant for psychosocial support [27]. At
both time points, the completed SIPP was handed to the
radiotherapist at the start of the consultation. Radio-
therapists had to check and discuss the scores of the
SIPP to get an impression of potential psychosocial pro-
blems and patients’ needs for psychosocial care. Radio-
therapists were asked to indicate on the SIPP whether
patients were offered an appointment with a psychoso-
cial care provider (e.g. psychologist, social worker, physi-
cian or nurse) and whether patients accepted their offer.
The study protocol was explained to the radiothera-
pists and other involved personnel at BVI (e.g. physi-
cian-assistants) [22]. Radiotherapists were trained in
using and interpreting the SIPP, including interpretation
of scores and the type of potential psychosocial pro-
blems and the need for psychosocial care during a one-
hour training session. Training was given by the
researcher and two social workers. Suitable cut-off
scores for symptoms were explained to radiotherapists.
A manual was prepared with interpretation of the
scores.
Measurement
Baseline characteristics of the patients and radiotherapists
Socio-demographic variables were assessed directly after
the first consultation (Table 2). Medical status before
RT included cancer site, tumour classification (TNM)
and the Karnofsky Performance Index. Variables were
extracted from patients’ medical records. Socio-demo-
graphic variables of the radiotherapists such as age, sex
and number of years of work experience were obtained
via personnel records of BVI.
Questionnaire to assess patients’ perspectives
Data on patients’ perspectives of the usefulness and fea-
sibility of the SIPP were collected using a self-report
questionnaire. The questionnaire was completed directly
after the first consultation (see Figure 1). This question-
naire included: one open-ended question about the time
(in minutes) taken to complete the screening instru-
ment; 11 items including written statements assessing
experiences with the instrument (Table 3: items 2-12)
and two open questions for suggestions for improve-
ment of the SIPP and other remarks (Table 3: items 13-
14). The 11 items were rated on a scale ranging from 0
to 10. Higher scores indicated a more positive opinion.
The items 2-4 were related to the content of the SIPP
(total score range 0-30, Cronbach’sa l p h a=0 . 6 8 )a n d
the items 5-12 concerned patients’ perspectives about
communication (total score range 0-80, Cronbach’s
alpha = 0.84).
Questionnaires to assess radiotherapists’ perspectives
Data on the radiotherapists’ perspectives on the useful-
ness and feasibility of the SIPP were collected using a
self-report questionnaire completed by radiotherapists
directly after the first consultation with a patient. This
questionnaire contained three items including written
statements assessing experiences with the SIPP (Table 4:
i t e m s1 - 3 )a n do n eo p e nq u e s t i o na b o u tt h et i m e( i n
minutes) that was required to discuss the SIPP with the
patient (Table 4: item 4). The three items were each
rated on a scale ranging from 0 to 10 (items 1-3, total
score range 0-30, Cronbach’s alpha = 0.89). Higher
scores indicated a more positive evaluation.
Seven and 13 months after the start of the study, the
radiotherapists completed a questionnaire on the general
usefulness and feasibility of the SIPP. This included nine
items with written statements assessing experiences with
the SIPP (Table 4: items 5-13) and two open questions
for suggestions for improvement of the instrument or
other remarks. The nine items were rated on a scale
ranging from 0 to 10 (items 5-13, total score range 0-90,
Cronbach’s alpha = 0.98). Higher scores indicated a
more positive opinion. It should be noted that the last
three items (items 11-13) were measured only the sec-
ond time (13 months after the start of the study).
Data analysis
Mean differences between the scores on the first SIPP
and second SIPP were analyzed by using a paired t-test.
Quantitative data of the process study were analyzed by
means of descriptive statistics (e.g. length of time to
complete the SIPP, scores on the instruments). Qualita-
tive data (e.g. answers to open questions) were categor-
ized. For describing patients’ and radiotherapists’
different perspectives on the items of the 0-10 point
scales, the scores were categorized in negative (score ≤
4), moderate (scores of 5 and 6) and positive perspec-
tives (score ≥ 7). We used mean scores for separate
items as well as sum scores for scales across items.
Associations between patients’ and radiotherapists’ per-
spectives on the usefulness and feasibility of the SIPP
were analyzed with Pearson correlations. Non-para-
metric tests were used if data were not normally distrib-
uted. Analyses were performed with SPSS software
(version 17.0; SPSS Inc., Chicago, IL). The level of statis-
tical significance was set at 0.05 (two-tailed).
Results
Baseline characteristics of the patients and
radiotherapists
Sociodemographic and medical characteristics of the 268
patients are listed in Table 1.
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Page 3 of 12Table 1 Patients’ extent of psychosocial problems and amount of referred patients as assessed with the SIPP
SIPP before
first
consultation
(n = 263)
SIPP before
consultation at the
end of treatment
(n = 250)
SIPP before first
consultation
SIPP before consultation
at
the end of treatment
SIPP before first
consultation
SIPP before
consultation at the end of
treatment
Mean (SD) Mean (SD) P-value At least sub-
clinical
symptoms
n (%)
b
Referred
n (%)
At least sub-
clinical
symptoms
n (%)
b
Referred
n (%)
Clinical
symptoms
n (%)
c
Referred
n (%)
Clinical
symptoms
n( % )
c
Referred
n (%)
Physical complaints
(score range 0-14)
3.8 (3.1) 4.7 (3.2) 0.00* 93 (34.7) 21 (22.5) 113 (42.2) 7 (6.2) 69 (25.7) 16 (23.2) 92 (34.3) 7 (7.6)
Psychological complaints
(score range 0-20)
5.1 (4.4) 3.9 (4.3) 0.00* 101 (37.7) 29 (28.7) 67 (25.0) 8 (11.9) 41 (15.3) 20 (48.8) 31 (11.6) 6 (19.4)
Social problems
(score range 0-8)
0.6 (1.1) 0.5 (1.0) 0.01* 52 (19.4) 17 (32.7) 23 (8.6) 5 (21.7) 12 (4.5) 8 (66.7) 6 (2.2) 1 (16.7)
Sexual problems
a
(score range 0-6)
0.8 (1.3) 0.7 (1.2) 0.36 10 (3.7) 3 (30.0) 4 (1.5) 0 (0.0) 5 (1.9) 3 (60.0) 2 (0.7) 0 (0.0)
Total score
(score range 0-24)
10.4 (7.3) 9.8 (7.2) 0.18 149 (55.6) 31 (20.8) 126 (47.0) 9 (7.1) 93 (34.7) 28 (30.1) 97 (36.2) 9 (9.3)
SD: Standard deviation
*The level of statistic significance is 0.05 (two-tailed). A Holm-bonferroni correction was applied for multiple comparisons.
a In order to calculate the mean score of sexual problems, the answer category “Not Applicable” was scored as a missing value.
Cut-off scores:
b An indication for at least sub-clinical symptoms (at least moderate) of psychosocial problems is to fulfill to one of more of the cut-off scores as described below:
1. Cut-off score of ≥ 5 on the physical complaints subscale
2. Cut-off score of ≥ 6 on the psychological complaints subscale
3. Cut-off score of ≥ 1 on the item: “Would you like to discuss these problems with someone” on the social/financial problems subscale
4. Cut-off score of ≥ 1 on the item: “Would you like to discuss these problems with someone” on the sexual problems subscale
cAn indication for clinical symptoms (high) of psychosocial problems is to fulfill to one of more of the cut-off scores as described below:
1. Cut-off score of ≥ 6 on the physical complaints subscale
2. Cut-off score of ≥ 10 on the psychological complaints subscale
3. Cut-off score of 2 on the item: “Would you like to discuss these problems with someone” on the social/financial problems subscale
4. Cut-off score of 2 on the item: “Would you like to discuss these problems with someone” on the sexual problems subscale
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2Figure 1 shows the flowchart of the number of
patients in each stage of the screening procedure. In
total, 23 patients did not complete the SIPP the first (n
= 5) or second (n = 18) time, of which one patient did
not complete the SIPP at both times. In total, 7 patients
(2.6%) did not complete the process evaluation forms.
The SIPP was applied by seven radiotherapists. Three
were female. The mean age was 44.6 (SD = 10.0) years
(range 30 to 63 years), and on average they had worked
for 14.1 years (range 4 to 35 years) as a radiotherapist.
The process evaluation forms on the usefulness and
feasibility of the SIPP after each first consultation with
the patient were completed by five radiotherapists for
146 patients. Two radiotherapists never completed this
form. One radiotherapist never checked the SIPP for
potential psychosocial problems for all his 54 participat-
ing patients. So, questions in the evaluation form after
each first consultation were not applicable for him/her.
The other radiotherapist reported that completing the
form after each patient took too much time.
Six radiotherapists completed twice the overall (i.e.
not patient-specific) process evaluation forms on the
usefulness and feasibility of the SIPP. Two radiothera-
pists did not complete the first or second process eva-
luation form due to the fact that one radiotherapist had
treated only one participating patient and another radio-
t h e r a p i s tn ol o n g e rw o r k e da tt h eB V Ia ta b o u t8
months after the start of the study.
Psychosocial problems as assessed with the SIPP
Table 2 shows patients’ extent of psychosocial problems
measured with the SIPP at the two time points before
the consultation with the radiotherapists. Furthermore,
the numbers of referred patients with symptoms of psy-
chosocial problems to a caregiver are presented. At the
end of the RT patients reported a significantly lower
extent of psychological and social problems (paired t-
test, P <0 . 0 1a n dP = 0.01, respectively), but signifi-
cantly more physical complaints (paired t-test, P <0 . 0 1 )
than during the first consultation. During the first con-
sultation a total of 33 patients were offered the opportu-
nity to consult a psychosocial care provider as a result
of the screening procedure. Of these 33 patients, 31
patients suffered from at least sub-clinical symptoms, of
which 28 patients suffered from clinical symptoms
(Table 2) and two patients hardly suffered from any
symptoms of psychosocial problems at all (not tabu-
lated). Since 28 of the 31 patients suffered from clinical
symptoms this indicates that three patients suffered only
from sub-clinical symptoms. Twenty-one patients
Table 2 Characteristics of the patients (n = 268)
Variables n %
Age (years)
Mean (SD) 62.4 (10.8)
Range 30.0-88.0
Sex
Female 183 68.3
Marital status
Married/living together 207 77.2
Unknown 5 1.9
Educational level
Elementary 103 38.4
High school 116 43.3
Higher Education/University 43 16.0
Unknown 6 2.2
Diagnosis
Prostate/Bladder 50 18.7
Lung 21 7.8
Breast 145 54.1
Cervix/Endometrial 9 3.4
Rectum 40 14.9
Non-Hodgkin Lymphoma 3 1.1
T-status (size of the primary tumor)
Tin-situ 7 2.6
T1/T2 152 56.7
T3/T4 58 21.6
Unknown 51 19.0
N-status (degree of spread lymph nodes)
N0 141 52.6
N1/N2 64 23.9
N3/N4 5 1.9
Unknown 58 21.6
M-status (presence of metastasis)
M0 203 75.7
Unknown 65 24.3
Karnofsky Performance Index
a
100/90 194 72.4
80/70 24 8.9
Unknown 50 18.7
Chemo therapy
Before radiotherapy treatment 66 24.6
During radiotherapy treatment 25 9.3
Time frame between start and end of the
radiotherapy treatment (days)
Mean (SD) 38 (6.7)
Median 37
Range (16-65)
SD: Standard deviation
a Score range 0-100, higher score indicates better physical functioning
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Page 5 of 12accepted the recommendation and were referred to a
psychosocial care provider (not tabulated). During the
consultation at the end of the RT, all nine patients who
were offered the opportunity to consult a caregiver suf-
fered from clinical symptoms (Table 2).
Patients’ perspectives on the usefulness and feasibility of
the SIPP
Ratings of patients’ perspectives about completing and
discussing the SIPP after the first consultation are
described in Table 3. On average, completing the SIPP
took 5.3 minutes and 71.6% of the patients completed
the SIPP in five minutes or less (not tabulated). Patients
were positive about the content of the SIPP. The mean
scores on the three items of the instruments’ content
subscale (items 2-4) varied from 8.0 to 8.9. Regarding
communication aspects, most patients (67.5%) were
positive about the importance of discussing items of the
SIPP with their radiotherapist. However, patients were
not positive about the usefulness of the SIPP to discuss
psychosocial complaints and sexual problems.
Patients’ suggestions for improvement of the SIPP
Five patients made suggestions for improvement. One
patient suggested adding an item on cognitive function-
ing, and one patient suggested adding an item about
medication use. Furthermore, one patient considered it
important to ask about problems at work, while another
patient reported that questions on specific tumours or
treatment of specific complaints were lacking. One
patient would have preferred an item about receiving
care at home.
1364 Patients were 
asked for participation 
Did not meet the inclusion criteria (n=111)  
Did meet the exclusion criteria (n=130) 
  ≤ 10 fractions of RT (n=26) 
  Unable to read and speak Dutch (n=12) 
  Unable to complete questionnaires (n=92) 
568 Patients signed informed  
consent form (50.6%) 
1123 Patients  
were eligible 
Refused participation (total n=555, EXP n=287) 
  Duration study of 1 year too long (total n= 164, EXP n=94) 
  Completing questionnaires takes too much time  
(total  n=38, EXP n=17) 
  No interest (total n=25, EXP n=18) 
  Consider themselves too old (total n=14, EXP n=8) 
  Study not important (total n=30, EXP n=13) 
  Participating in study elsewhere (total n=17, EXP n=9) 
  Getting social support and experiencing no problems 
 (total n=11, EXP n=6) 
  Reason unknown (total  n=135, EXP n=75) 
  Other reasons (total  n=121, EXP n=47) 
268 Patients linked to one 
of the seven 
radiotherapists of 
experimental group (EXP)  
300 Patients linked to 
one of the seven 
radiotherapists of 
control group (CON)  
In total, 5 of the 268 patients did not 
complete the SIPP before first 
consultation  
First consultation, 
before radiotherapy 
treatment 
Directly after consultation: 
5 of the 7 radiotherapists 
completed in total 122 
process-evaluation forms after 
seeing participating patients 
Directly after first consultation: 
7 of the 268 patients did not complete the 
process-evaluation form 
In total, 18 of the 268 patients did not 
complete the second SIPP before 
consultation at the end of radiotherapy 
treatment 
Consultation at the end of 
radiotherapy treatment 
Figure 1 CONSORT flow diagram of the patients’ inclusion procedure and data collection process evaluation (grey blocks).
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Page 6 of 12Radiotherapists’ perspectives on the usefulness and
feasibility of the SIPP
Ratings of radiotherapists’ perspectives on using the
SIPP after the first consultation are presented in the
upper part of Table 4.
In 90.1% of all consultations, the time required to dis-
cuss the instrument was less than five minutes (not
tabulated). With respect to specific evaluation after each
consult, radiotherapists were most positive about the
fact that the SIPP gave better insight into the psychoso-
cial well-being of the patient. They were less positive
about the fact that the SIPP invited them to ask about
the patients’ psychosocial well-being.
Radiotherapists’ overall perspectives on using the SIPP
were measured at two time points: about seven and 13
months after the start of the study. Their overall per-
spectives on the usefulness and feasibility of the SIPP
was mixed (mean scores varied from 1.5 to 6.0; see
Table 3 Patients’ perspectives on the usefulness and feasibility of the SIPP
Scores:
theoretical
range
n Mean
score
(SD)
Scores:
observed
range
Negative
perspective
(%)
a
Score ≤ 4
Moderate
perspective
(%)
a
Score 5, 6
Positive
perspective
(%)
a
Score ≥ 7
1. Time to complete the screening instrument Open question
(minutes)
256 5.3 (3.5) 1-20 —— —— ——
Instruments’ content subscale:
2. Understanding the items 0(Not easy to
understand)-
10(Easy to
understand)
258 8.9 (1.3) 0-10 0.4 2.2 93.7
3. The instrument is pleasant to complete 0(Not pleasant
to complete)-
10(Very pleasant
to complete)
259 8.4 (1.5) 0-10 1.5 3.7 91.5
4. Importance of the subjects 0(Not
important)-
10(Very
important)
258 8.0 (1.6) 0-10 1.5 11.5 83.2
Communication aspects subscale:
5. Importance of discussing
the screening instrument with radiotherapist
0(Not
important)-
10(Very
important)
237 7.4 (2.3) 0-10 8.0 12.7 67.5
6. Physical complaints in the screening instrument were
discussed with radiotherapist
0(Not discussed)
-
10(Extensively
discussed)
250 6.2 (3.1) 0-10 18.9 17.9 56.3
7. Psychosocial complaints in the screening instrument
were discussed with radiotherapist
0(Not
discussed)-
10(Extensively
discussed)
249 4.6 (3.6) 0-10 37.3 16.5 39.3
8. Sexual problems in the screening instrument were
discussed with radiotherapist
0(Not
discussed)-
10(Extensively
discussed)
241 1.6 (2.7) 0-10 73.1 7.5 9.3
9. The screening instrument was a useful tool to discuss
physical complaints with radiotherapist
0(Not useful)-
10(Very useful)
246 4.1 (3.6) 0-10 43.7 17.5 30.6
10. The screening instrument was a useful tool to discuss
psychosocial complaints with radiotherapist
0(Not useful)-
10(Very useful)
242 3.5 (3.6) 0-10 48.4 15.3 26.5
11. The screening instrument was a useful tool to discuss
sexual problems with radiotherapist
0(Not useful)-
10(Very useful)
234 1.7 (2.8) 0-10 67.7 10.8 8.9
12. Discussing the screening instrument scores with the
radiotherapist was pleasant
0(Not pleasant)-
10(Very pleasant)
223 6.4 (2.7) 0-10 11.2 24.6 47.4
Open questions for remarks
13. Is there a subject that was missing from the
screening instrument?
No-Yes, namely... 5 —— —— —— —— ——
14. Have you any remarks? No-Yes, namely... 0 —— —— —— —— ——
SD: Standard deviation
aDue to possible missing values for several items, not all the scores add up to 100%
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Page 7 of 12Table 4 Radiotherapists’ perspectives on the usefulness and feasibility of the SIPP
Scores:
theoretical
range
n Mean
score
(SD)
Scores:
observed
range
Negative
perspective
(%)
c
Score ≤ 4
Moderate
perspective
(%)
c
Score 5, 6
Positive
perspective
(%)
c
Score ≥ 7
After first consultation for each patient
1. The screening instrument invited to ask about the
patient’s psychosocial well-being
0 (Not used) -
10 (Fully used)
146 5.9 (2.8) 0-10 17.8 6.2 30.3
2. The scores gave better insight into the patient’s
psychosocial well being
0(Less insight)
-
10(Very much
insight)
146 6.5 (2.4) 0-10 12.3 4.1 36.2
3. Exchanging information about the subjects in the
screening instrument gave better insight into the patient’s
psychosocial well being
0(Less insight)
-
10(Very much
insight)
146 6.3 (2.6) 0-10 16.2 4.1 34.4
4. Time required to discuss the instrument Open
question
(minutes)
142 4.3 (2.5) 0-15 —— —— ——
More generally
5. Contribution of using the screening instrument for
discussing physical complaints
0 (No
contribution) -
10 (Very good
contribution)
6
a
6
b
3.2 (3.2)
3.5 (3.7)
0-7
0-8
66.7
66.7
0.0
0.0
33.3
33.3
6. Contribution of using the screening instrument for
discussing psychosocial complaints
0 (No
contribution) -
10 (Very good
contribution)
6
a
6
b
4.7 (3.9)
3.7 (3.9)
0-8
0-9
50.0
66.7
0.0
0.0
50.0
33.3
7. Contribution of using the screening instrument for
discussing sexual problems
0(No
contribution)-
10(Very good
contribution)
6
a
6
b
3.7 (4.0)
3.5 (4.4)
0-9
0-10
66.7
66.7
0.0
0.0
33.3
33.3
8. Usefulness of discussing (the scores on) the screening
instrument
0(Not useful)-
10(Very useful)
6
a
6
b
4.8 (4.0)
4.0 (4.2)
0-9
0-9
33.3
66.7
16.7
0.0
50.1
33.3
9. Discussing (the scores on) the screening instrument with
the patient was pleasant
0(Not
pleasant)-
10(Very
pleasant)
6
a
5
b
4.3 (3.5)
6.0 (4.1)
0-8
0-10
33.3
33.4
33.4
0.0
33.3
33.4
10. Contribution of discussing the screening instrument to a
better quality of consultation
0(No positive
contribution) -
10(Very
positive
contribution)
5
a
5
b
5.4 (3.4)
4.4 (4.0)
0-9
0-9
40.0
50.1
0.0
0.0
60.0
33.4
11. Indication of the scores for referring patients to social
caregivers
0(No good
indication)-
10(Very good
indication)
—
5
b
—
4.2 (3.7)
—
0-9
—
24.9
—
0.0
—
16.6
12. Changing communication style
by using the screening instrument
0(No
changing)-
10(Changing)
—
6
b
—
1.5 (2.1)
—
0-5
—
41.6
—
8.3
—
0.0
13. Feasibility of using the screening instrument during
consultations for patients to bring up psychosocial problems
0(Not
feasible)-
10(Feasible)
—
6
b
—
3.8 (3.9)
—
0-9
—
33.3
—
0.0
—
16.6
Open questions for remarks
14. Is there a subject that was missing from the screening
instrument?
No-Yes,
namely...
2 —— —— —— —— ——
15. Have you any remarks? No-Yes,
namely...
2 —— —— —— —— ——
SD: Standard deviation
a First measurement, 7 months after the start of the study
b Second measurement with 3 additional items (item 7-9), 13 months after the start of the study
c Due to possible missing values for several items, not all the scores add up to 100%
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t h eS I P Pt ob eu s e f u la n df e a s i b l e .N o n eo ft h er a d i o -
therapists was positive about changing their communi-
cation style by using the SIPP.
Radiotherapists’ suggestions for improvement of the SIPP
Two radiotherapists made suggestions for improvement.
O n ep r e f e r r e dat u m o u r - s p e c i f i cq u e s t i o n n a i r ea b o v ea
disease-specific questionnaire and another suggested an
item about whether patients already received psychoso-
cial support. Regarding feasibility, one radiotherapist
suggested that physician-assistants should discuss the
screening instrument with the patients.
Associations between patients’ and radiotherapists’
perspectives on the usefulness of the screening
instrument
Radiotherapists who considered the screening instru-
ment a useful tool to ask about psychosocial well-being
aspects (Table 4 item 8) were more likely to discuss psy-
chosocial complaints (r = 0.2, P = 0.01) and sexual pro-
blems (r = 0.3, P < 0.01) with their patients (Table 3
items 7 and 8, respectively). Patients were more likely to
report that discussing the items of the SIPP with their
radiotherapist was pleasant (Table 3 item 12) if the
radiotherapist considered the SIPP to be a useful tool to
ask about psychosocial well-being (r = 0.2, P < 0.05)
(Table 4 item 8).
Discussion
This study explored the usefulness and feasibility of
using a screening instrument as the SIPP in a radiation
oncology department according to radiotherapists and
patients. Nearly all patients completed the SIPP twice, at
the beginning and at the end of RT, which is an indica-
tion of an acceptable feasibility of the screening instru-
ment. Just as previous studies reported that not all
radiotherapists were willing to use psychosocial screen-
ing instruments [19,28] in our study also one radio-
therapist was not willing to use the screening
instrument.
T h ep r e v a l e n c er a t eo fp s y c h o s o c i a lp r o b l e m sa m o n g
patients receiving RT with curative intent was in line
with previous studies [1,29]. During the treatment tra-
jectory patients seemed to experience different problems
at different time points; the extent of psychological and
social problems was lower at the end of RT, while the
extent of physical complaints was higher at this time
point. The latter was probably due to the high extent of
side-effects at the end of RT since patients had received
the maximum radiation doses. Displaying similarities
with other studies [30-32], a relative small proportion of
patients suffering from at least sub-clinical (7.1%-20.8%)
or clinical (9.3%-30.1%) symptoms of psychosocial
problems were offered the opportunity to visit a psycho-
social care provider by their radiotherapist (Table 2). An
explanation might be that psychosocial problems were
discussed sufficiently during the consultation, which
meant that receiving psychosocial support by a psycho-
social care provider was not considered necessary any
more [33]. Another explanation might be that according
to Livingston and colleagues, physicians may be uncom-
fortable referring patients at a time when patients are
overloaded with information (e.g. treatment, and side-
effects) [34], as is the case during a first consultation.
Also, physicians tend to ignore raw scores on question-
naires when they have to add them up and interpret
them themselves, resulting in under diagnosis of patients
suffering from psychosocial problems [35]. The latter
can be prevented by using a computer-based screening
instrument that forwards the screening data and pre-
sents the results directly to physicians. However, Boyes
and colleagues reported that giving physicians feedback
about patients’ psychosocial well-being rarely contribu-
ted to physicians’ decision making about patient man-
agement [28]. Furthermore, contrary to other studies
[31,36-41], our results showed that when offered during
the first consultation, the majority of the patients
(63.6%) accepted psychosocial care. It seemed that
receiving psychosocial support was acceptable for
patients at that time point. A previous study reported
that patients’ need and acceptance for psychosocial sup-
port seemed to be related to timing [38]. Still, it should
b et a k e ni n t oa c c o u n tt h a ta b o u to n e - t h i r do ft h e
patients did not wish to be referred to a psychosocial
care provider, which may imply that for some patients a
barrier emerged that impeded acceptance of referral
[40].
There is a discrepancy between radiotherapists’ and
patients’ perspectives of the usefulness and feasibility of
the SIPP. Patients’ perspectives of the usefulness and
feasibility of the SIPP were moderate to good in general.
Comparable with the study of Pruyn and colleagues
[25], two-thirds of the patients were very positive on the
importance of discussing the screening instrument with
their radiotherapist. Regarding the radiotherapists’ per-
spectives, only a minority of radiotherapists considered
the SIPP to be useful and feasible. Despite the latter, it
is important to note that our outcomes showed a posi-
tive association between radiotherapists’ opinion about
the scores as good indicators into patients’ well-being
and discussing psychological problems. However, it can
be vice versa: radiotherapists who traditionally more
often discuss psychosocial problems were those who
indicated that the screening instrument gave better
insight into patients’ problems. Furthermore, discussing
the screening instrument was more pleasant for patients
when the radiotherapists were positive about discussing
Braeken et al. BMC Cancer 2011, 11:479
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have positive attitudes towards discussing psychosocial
problems patients’ perspectives of the usefulness of the
tool will be more positive. Moreover, it also indicates
the importance of patient-physician communication for
high-quality care, as it may influence patients’ satisfac-
tion with care [13,20,42].
Some results of this study were remarkable. Radio-
therapists were quite positive about the usefulness and
feasibility of the screening instrument when they evalu-
ated the SIPP directly after each first consultation with
their patient, but more negative when the usefulness
and feasibility was evaluated in general and not related
to a specific consultation. A reasonable explanation is
the different numbers of radiotherapists who completed
the questionnaires in both situations. As reported ear-
lier, two radiotherapists did not report their opinion
after each consultation. Yet, despite the assumption that
using a screening instrument may initiate better com-
munication between patients and medical staff [7,12],
none of the radiotherapists were convinced that using
the screening instrument would change their communi-
cation style.
This study has several strong elements: the large num-
ber of patients that was included as well as the perspec-
tives of both patients and radiotherapists. The study has
limitations as well. First, the study was conducted in a
single radiotherapy department, and although the num-
ber of patients was large, the number of radiotherapists
was limited. This reduces the options for generalization
of the results. Second, because the SIPP had not yet
been incorporated into routine care, the radiotherapists
might have gained insufficient experience to check the
SIPP scores and patients’ needs for psychosocial care.
Partly, this could explain why radiotherapists considered
the usefulness and feasibility of the screening instrument
generally as low, while actual scores were mixed.
Recommendations for improving the use of a screen-
ing instrument in practice include encouraging screen-
ing at several time points as patients’ needs and extent
of psychosocial problems may change during the treat-
ment trajectory. Furthermore, an important issue is to
change and improve the physicians’ attitudes regarding
psychosocial care. This is relevant since physicians’ atti-
tudes toward discussing emotional problems may influ-
ence detection of psychosocial problems [21] and are
linked with patients’ satisfaction [13]. Additional skills
training among physicians may be needed to improve
recognition and management of psychosocial problems
in cancer patients [43]. However, it could also be that
nurses rather than physicians prove to be the most sui-
table health care professionals to discuss psychosocial
problems with cancer patients. Studies reported that
nurses were more willing to use screening tools than
physicians [19]. Further research is necessary to opti-
mize the use of screening instruments that may identify
cancer patients’ extent of psychosocial problems and
improve health-related outcomes.
Conclusion
Overall, we can conclude that the SIPP screening proce-
dure appeared to be feasible in a radiotherapy depart-
ment and that the screening procedure appears to be
valued positively by most cancer patients, but not by all
radiotherapists. It is useful to reflect on the fact that
two-thirds of the patients rated the discussion with their
radiotherapist about psychosocial problems as (highly)
important. So, improving radiotherapists’ attitudes
towards discussing emotional problems and using
screening instruments may not only improve the useful-
ness of a screening instrument like the SIPP, but also
patients’ satisfaction with care.
Appendix A: Screening Inventory of Psychosocial
Problems (SIPP) (Additional file 1)
Additional material
Additional file 1: Screening Inventory of Psychosocial Problems
(SIPP)
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